Teleflex Incorporated (TFX) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 47 PAGES: 55

Teleflex Incorporated (TFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Teleflex Incorporated (Teleflex) is a medical device company. It undertakes the development, de

More Info
									            Teleflex Incorporated (TFX) - Financial and Strategic SWOT Analysis
                                           Review
        Reference Code: GDME810FSA                                                                                            Publication Date: JUN 2013

          155 South Limerick Road                            Phone              +1 610 9485100                  Revenue          1,551 (million USD)
          Limerick, PA                                       Fax                +1 610 9485101                  Net Profit       -190.06 (million USD)
          19468                                              Website            www.teleflex.com                Employees        11,600
                                                                                TFX [New York Stock
          United States                                      Exchange                                           Industry         Medical Equipment
                                                                                Exchange]

       Company Overview
       Teleflex Incorporated (Teleflex) is a medical device company. It undertakes the development, design, manufacture and
       distribution of medical devices used in critical care and surgery. The company provides supply single-use medical devices used
       by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications.
       Teleflex offers its products in four product categories, namely, critical care, surgical care, cardiac care and OEM and development
       services. The company carries out its operations across 130 countries and its key market includes the US, Europe, Asia and
       Australia.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Teleflex Incorporated, SWOT Analysis
         Benson F. Smith                     Chairman                                 Strengths                              Weaknesses
         Laurence G. Miller                  Chief Administrative Officer
                                                                                      Increased Profitability Ratios         FDA Warning Letter
         Thomas E Powell                     Chief Financial Officer
                                                                                      Broad Product Portfolio                Voluntary Product Recalls
         Sigismundus W. W. Lubsen            Director
         Patricia C. Barron                  Director
        Source: Annual Report, Company Website, Primary and Secondary
                                                                                      Opportunities                          Threats
        Research, GlobalData
                                                                                      Market Growth in Emerging              Rapid Technological Change
       Share Data                                                                     Economies
                                                                                                                             Compliance to Various
         Teleflex Incorporated
                                                                                      Significant Divestitures and           Regulations
        Share Price (USD) as on 07-Jun-                                78.42          Acquisitions
        2013
        EPS (USD)                                                         NA
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        Market Cap (million USD)                                       3,224         GlobalData

        Enterprise Value (million USD)                                 3,893
        Shares Outstanding (million)                                       41
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      May 29, 2013         Teleflex  To     Showcase     Comprehensive
                                                                                                           Anesthesia Portfolio At Euroanaesthesia 2013
                                                                                      May 16, 2013         Teleflex To Showcase Arrow Advanced
                                                                                                           Interventional Radiology Portfolio At EuroPCR
                                                                                      May 09, 2013         Teleflex   To     Showcase   Hudson                 RCI
                                                                                                           Respiratory Solutions At FOCUS 2013
                                                                                      Apr 30, 2013         Teleflex To Show Enhanced Line Of Pain
                                                                                                           Management Solutions At 38th Annual ASRA
                                                                                                           Regional Anesthesia And Acute Pain Medicine
       Source: Annual Report, Company Website, Primary and Secondary
                                                                                                           Meeting
       Research, GlobalData                                                          Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData




Teleflex Incorporated (TFX) - Financial and Strategic SWOT                                                                       Reference Code: GDME810FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                       Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Teleflex Incorporated - Key Facts....................................................................................................................................................... 5
       Teleflex Incorporated - Key Employees .............................................................................................................................................. 6
       Teleflex Incorporated - Key Employee Biographies ............................................................................................................................ 7
       Teleflex Incorporated - Major Products and Services ......................................................................................................................... 8
       Teleflex Incorporated - Medical Equipment Pipeline Products Data ................................................................................................. 11
          Teleflex Incorporated Pipeline Products by Equipment Type........................................................................................................ 11
          Teleflex Incorporated Pipeline Products by Development Stage .................................................................................................. 13
       Teleflex Incorporated - History ......................................................................................................................................................... 15
       Teleflex Incorporated - Company Statement .................................................................................................................................... 21
       Teleflex Incorporated - Locations And Subsidiaries ......................................................................................................................... 23
          Head Office ................................................................................................................................................................................... 23
          Other Locations & Subsidiaries ..................................................................................................................................................... 23
       Teleflex Incorporated - Key Manufacturing Facilities ........................................................................................................................ 26
       Section 2 – Company Analysis ......................................................................................................................................................... 27
       Teleflex Incorporated - Business Description ................................................................................................................................... 27
          Business Description - Medical ..................................................................................................................................................... 27
             Medical - Overview .................................................................................................................................................................... 27
             Medical - Financials................................................................................................................................................................... 28
             Medical - Capital Expenditure ................................................................................................................................................... 28
             Medical - Market View ............................................................................................................................................................... 28
             Medical - Technology ................................................................................................................................................................ 28
       Teleflex Incorporated - SWOT Analysis............................................................................................................................................ 29
          SWOT Analysis - Overview........................................................................................................................................................... 29
          Teleflex Incorporated - Strengths .................................................................................................................................................. 29
             Strength - Increased Profitability Ratios .................................................................................................................................... 29
             Strength - Broad Product Portfolio ............................................................................................................................................ 29
             Strength - Diversified Geographical Presence .......................................................................................................................... 29
             Strength - Strong Research and Development Activities........................................................................................................... 30
          Teleflex Incorporated - Weaknesses ............................................................................................................................................ 30
             Weakness - FDA Warning Letter ............................................................................................................................................... 30
             Weakness - Voluntary Product Recalls ..................................................................................................................................... 30
          Teleflex Incorporated - Opportunities ............................................................................................................................................ 31
             Opportunity - Market Growth in Emerging Economies .............................................................................................................. 31
             Opportunity - Significant Divestitures and Acquisitions ............................................................................................................. 31
             Opportunity - Distribution Agreement ........................................................................................................................................ 31
             Opportunity - New Product Launches........................................................................................................................................ 31
             Opportunity - Global Anesthesia and Respiratory Devices Market............................................................................................ 32
          Teleflex Incorporated - Threats ..................................................................................................................................................... 32
             Threat - Rapid Technological Change ....................................................................................................................................... 32
             Threat - Compliance to Various Regulations ............................................................................................................................. 32
             Threat - Cost Containment Pressures ....................................................................................................................................... 32


Teleflex Incorporated (TFX) - Financial and Strategic SWOT                                                                                                        Reference Code: GDME810FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
             Threat - Relationships with Physicians ...................................................................................................................................... 33
       Teleflex Incorporated - Key Competitors .......................................................................................................................................... 34
       Section 3 – Company Financial Ratios ............................................................................................................................................. 35
       Financial Ratios - Capital Mar
								
To top